A case of acute pericarditis and subsequent pericardial effusion in COVID-19 patient: a case report

Osman, Waddah; Ahmed, Abdelmuniem; Elawad, Omer Ali Mohamed Ahmed; Albashir, Ahmed Abdalazim Dafallah

doi:10.22541/au.159969834.49964606

Cited by 4 publications

(4 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Meanwhile, cardiac involvement of various types has been observed throughout the literature [ 11 ]. PE, which is the buildup of fluid in the pericardium, is one of the cardiovascular complications of COVID-19 which has rarely been reported - both during and after the viral infection [ 12 , 13 ]. According to the existing literature, most reports of COVID-19 related PE were non-hemorrhagic, with only a few hemorrhagic cases being present [ 9 , 14 ].…”

Section: Discussionmentioning

confidence: 99%

Post COVID-19 hemorrhagic pericardial effusion; A case report with literature review

Amin¹,

Kakamad

Hamasaeed

et al. 2022

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

Introduction Pericardial effusion (PE) related to COVID-19 has rarely been observed, with most reported cases being non-hemorrhagic. This study aims to present a rare case of post-COVID-19 hemorrhagic PE. Case report A 44-year-old male presented with shortness of breath upon exertion, palpitation, and left-sided chest tightness. He was a recently recovered from COVID-19. He was conscious, oriented, tachypneic, and tachycardic. Chest examination revealed a mixture of fine and coarse crackles along with muffled heart sounds. He had elevated D-dimer, C-reactive protein, prothrombin time, and aPTT. Computed tomography pulmonary angiogram showed acute pulmonary thromboembolism involving the posterior segmental lobar branch of the left lower lobe with concomitant pulmonary infarction. Echocardiography showed severe PE without diastolic collapse. Pericardial drainage was performed and by the 2nd day, there was no more effusion. On the 7th day, the patient developed severe complications which led to cardiac arrest. Discussion PE is the buildup of fluid in the pericardium. It has been rarely observed in relation to COVID-19, both during and after the viral infection. If PE is suspected, Echocardiography can be used to confirm its diagnosis. There is no standard management for these cases and only non-hemorrhagic patients with mild to moderate effusion can be treated using conservative measures. Conclusion Hemorrhagic PE can be a rare but possible post-COVID-19 sequel, and Echo can be used to confirm its diagnosis. Drainage is necessary to resolve the effusion.

show abstract

Section: Discussionmentioning

confidence: 99%

Post COVID-19 hemorrhagic pericardial effusion; A case report with literature review

Amin¹,

Kakamad

Hamasaeed

et al. 2022

Annals of Medicine &Amp; Surgery

View full text Add to dashboard Cite

show abstract

“…In addition, SARS-CoV-2 infection induces an excessive inflammatory response. This inflammation is responsible for pericardial effusions or cardiac tamponade [20,22].…”

Section: Cardiovascular Complicationsmentioning

confidence: 99%

Post-COVID-19 Condition and Its Presence in Mexico

Navarro-Olivos¹,

Flores-Vargas²,

Morales-Reyes³

et al. 2023

Post COVID-19 - Effects on Human Health

View full text Add to dashboard Cite

In this chapter, we discuss general information about the post-COVID-19 condition, also known as long COVID. Since it is still under research, many questions remain unanswered. Nevertheless, post-acute complications due to infections have been previously reported for other viruses. Among those complications that remain are anosmia, fatigue, cardiovascular, and pulmonary. The evidence so far suggests that these complications decrease with time. The most worrying persistent symptoms due to COVID-19 are related to neurological damage. Most post-COVID-19 complications can be treated in a standard way, but their impact on life quality is unknown. Finally, we present a rough landscape of long COVID-19 in Mexico and Latin America. More studies are needed to study this condition and its impact on public health.

show abstract

“…19 En el plasma de pacientes con síntomas postagudos, existen niveles elevados de marcadores de inflamación crónica como IL-17A, factor de células madre (SCF), IL-12p70, IL-1, y de reparación endotelial y angiogénesis, como la proteína inflamatoria de macrófagos (MIP-1), el factor neurotrófico derivado del cerebro (BDNF), el factor de crecimiento endotelial vascular (VEGF), la proteína quimioatrayente de monocitos (MCP-1) y el factor de creci- Progresión de la infección aguda de SARS-CoV-2 al síndrome post-COVID, la figura muestra las diversas formas de progresión de la infección aguda por SARS-CoV-2 a las categorías propuestas de COVID-19 postaguda y síndrome post-COVID, cada una con los síntomas reportados. 7,8,13,29,31,37,[47][48][49] 20 Si la enfermedad inicial es severa, es posible que se desarrolle el síndrome postcuidados intensivos, definido como el desarrollo de deficiencias o el agravamiento de las mismas, lo cual empeora el estado de salud física, cognitiva o mental después de una enfermedad crítica y que persiste más allá de la hospitalización por cuidados agudos. 18,21 Finalmente, el SARS-CoV-2 utiliza como receptor de entrada a la enzima convertidora de angiotensina-2 (ECA-2), expresada en el epitelio respiratorio, cardiovascular, gastrointestinal, urogenital y sistema nervioso central (SNC) y periférico (SNP), 22 lo que lo convierte en el principal mecanismo de lesión en los sistemas.…”

Section: Fisiopatologíaunclassified

“…Los virus causan inflamación pericárdica por mecanismos citotóxicos directos o inmunomediados, desarrollando pericarditis, derrame pericárdico y taponamiento, aunque el mecanismo exacto aún no se ha descrito, 37 se ha logrado aislar el SARS-CoV-2 en líquido pericárdico de pacientes infectados. 38 A su vez, en el sistema cardiovascular, los niveles elevados de ECA-2 permiten la invasión viral directa, asimismo, la respuesta inmunológica y citocinas causan una inflamación del músculo cardiaco, interfiriendo con el sistema de conducción y con la capacidad de bombeo del corazón, lo que da lugar a arritmias y paro cardiaco.…”

Section: Cardiovascularunclassified

Efectos a largo plazo de la COVID-19: una revisión de la literatura

Bautista¹,

Martínez²,

Vilchis³

et al. 2021

Acta Médica Grupo Ángeles

View full text Add to dashboard Cite

La COVID-19 tiene un amplio espectro de manifestaciones clínicas durante su curso y se han encontrado al menos 55 efectos a largo plazo que incluyen signos, síntomas y parámetros clínicos. Las etapas clínicas de la enfermedad se dividen en la fase aguda, fase postaguda y síndrome post-COVID-19. Estas fases se caracterizan por el desarrollo de signos y síntomas desde el inicio hasta cuatro semanas, entre cuatro a 12 semanas y más allá de 12 semanas, respectivamente. La prevalencia de signos y síntomas varía desde 35% hasta 94%; en la mayoría de los estudios (80%) predominan la fatiga, tos y disnea. Los potenciales mecanismos fisiopatológicos que explican el desarrollo de los síntomas incluyen la persistencia viral, alteraciones inmunológicas e inflamación, secuelas esperadas de una enfermedad crítica y cambios fisiopatológicos específicos de la enfermedad aguda en cada sistema. Hasta el momento, se desconoce el espectro completo del síndrome post-COVID; a pesar de haber identificado muchos de sus componentes clínicos aún faltan datos para reconocer el tiempo exacto de duración.

show abstract

A case of acute pericarditis and subsequent pericardial effusion in COVID-19 patient: a case report

Abstract: Acute pericarditis and pericardial effusion are rare extrapulmonary presentations of COVID-19. They can occur without concomitant pulmonary disease or myocardial injury. A high index of suspicion is necessary to assure early diagnosis and treatment.

Cited by 4 publications

References 7 publications

Post COVID-19 hemorrhagic pericardial effusion; A case report with literature review

Post COVID-19 hemorrhagic pericardial effusion; A case report with literature review

Post-COVID-19 Condition and Its Presence in Mexico

Efectos a largo plazo de la COVID-19: una revisión de la literatura

Contact Info

Product

Resources

About